Publicaciones en colaboración con investigadores/as de National Hospital Organization Kyushu Cancer Center (1)

2021

  1. Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial

    The Lancet Oncology, Vol. 22, Núm. 6, pp. 779-789